Hemostatic Disorders
Welcome,         Profile    Billing    Logout  
 195 Companies   327 Products   327 Products   167 Mechanisms of Action   13 Trials   3266 News 


«12...2324252627282930313233...6768»
  • ||||||||||  bortezomib / Generic mfg., prednisone / Generic mfg., bendamustine / Generic mfg.
    Enrollment closed:  Bendamustine, Bortezomib (Velcade  (clinicaltrials.gov) -  Apr 9, 2015   
    P2,  N=60, Active, not recruiting, 
    N=100 --> 120 | Trial primary completion date: Apr 2015 --> Mar 2016 Recruiting --> Active, not recruiting
  • ||||||||||  Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
    Trial completion, Phase classification, Enrollment change:  Viral Kinetics in HCV Clearance in Subjects With Hemophilia (clinicaltrials.gov) -  Apr 6, 2015   
    P1,  N=5, Completed, 
    N=60 --> 0 Active, not recruiting --> Completed | Phase classification: P4 --> P1 | N=20 --> 5
  • ||||||||||  Depocyte (liposomal cytarabine) / Mundipharma, Leadiant Biosci
    Trial completion, Enrollment change, Trial primary completion date:  Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease (clinicaltrials.gov) -  Apr 3, 2015   
    P=N/A,  N=2, Completed, 
    Recruiting --> Completed | Trial primary completion date: Oct 2011 --> Apr 2015 Recruiting --> Completed | N=29 --> 2 | Trial primary completion date: Dec 2016 --> Jan 2015
  • ||||||||||  melphalan / Generic mfg.
    Trial completion, Trial primary completion date:  Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients (clinicaltrials.gov) -  Apr 2, 2015   
    P2,  N=148, Completed, 
    Recruiting --> Completed | N=29 --> 2 | Trial primary completion date: Dec 2016 --> Jan 2015 Active, not recruiting --> Completed | Trial primary completion date: Apr 2015 --> May 2014
  • ||||||||||  melphalan / Generic mfg., lenalidomide / Generic mfg.
    Trial completion, Trial primary completion date:  Lenalidomide and High-Dose Melphalan (clinicaltrials.gov) -  Mar 31, 2015   
    P1/2,  N=61, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Mar 2015
  • ||||||||||  VLX1570 / Vivolux
    Enrollment open:  A Study of VLX1570 and Dexamethasone in Myeloma Patients (clinicaltrials.gov) -  Mar 31, 2015   
    P1/2,  N=65, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Mar 2015 Not yet recruiting --> Recruiting
  • ||||||||||  acetylcysteine solution / Generic mfg.
    Enrollment status, New P1 trial, Trial primary completion date:  NACinTTP: A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura (clinicaltrials.gov) -  Mar 26, 2015   
    P0,  N=3, Enrolling by invitation, 
    Recruiting --> Active, not recruiting Recruiting --> Enrolling by invitation | Trial primary completion date: May 2014 --> May 2016
  • ||||||||||  Enrollment open:  Colorado Adult Joint Assessment Scale (CAJAS) Validation (clinicaltrials.gov) -  Mar 25, 2015   
    P=N/A,  N=30, Recruiting, 
    Recruiting --> Enrolling by invitation | Trial primary completion date: May 2014 --> May 2016 Not yet recruiting --> Recruiting
  • ||||||||||  Trial completion, Enrollment change, HEOR:  Quality of Life Study of Helixate NexGen (clinicaltrials.gov) -  Mar 20, 2015   
    P=N/A,  N=78, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=150 --> 78
  • ||||||||||  CYAD-01 / Celdara Medical, Celyad Oncology
    Enrollment open, Trial primary completion date, Metastases:  Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands (clinicaltrials.gov) -  Mar 14, 2015   
    P1,  N=24, Recruiting, 
    Trial primary completion date: Jan 2016 --> May 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2017 --> Mar 2019
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma (clinicaltrials.gov) -  Mar 10, 2015   
    P2,  N=11, Terminated, 
    N=700 --> 11 | Recruiting --> Terminated | Trial primary completion date: Jan 2016 --> Feb 2015; Study was terminated due to inability to recruit enough patients that meet inclusion criteria. No analysis will be done.